* A retrospective analysis of 73 patients revealed that while younger age was a significant factor linked to fludarabine-induced bradycardia, the overall doses and durations of fludarabine did not show a statistically significant difference between those with and without bradycardia.
* It was found that discontinuation of fludarabine improved bradycardia in most cases, and the study emphasizes the importance of monitoring heart rates closely in younger patients receiving this treatment.